statistically – Page 9 – Communicable Diseases Research

Longitudinal Randomized Cohort Study of SARS-CoV-2 Antibody Seroprevalence in the St. Petersburg Population

상트페테르부르크 인구에서 SARS-CoV-2 항체 혈청유병성에 대한 종단 무작위 코호트 연구

Randomized Controlled Trial

Published on 2022-04-272022-09-11
Journal: Viruses [Category] COVID19(2023년), SARS, 임상, 진단, 치료기술, 치료법,

Results of a Randomized Trial Testing the Efficacy of Tele-Savvy, an Online Synchronous/Asynchronous Psychoeducation Program for Family Caregivers of Persons Living with Dementia

Randomized Controlled Trial

Published on 2022-04-202022-10-05
Journal: The Gerontologist [Category] 임상,

[키워드] accompanied adverse effect Alzheimer’s disease Anxiety approval ARMS baseline benefit Care Caregiver Caregiver stress clinically Cohort coronavirus disease Dementia Depression Effect effect sizes Efficacy eligible emotional enrolled examined family Family caregiver finding group IMPROVE Increases individual Linear model Mastery. moderate outcome Perceived stress Person Prevalence problems Program Psychoeducation Psychological Psychological well-being Randomized randomized trial recipient Research design Result Safety Monitoring Board Savvy statistically synchronous tested Testing Trial usual care viability
[DOI] 10.1093/geront/gnab029 PMC 바로가기 [Article Type] Randomized Controlled Trial

Assessment of the Impact of COVID-19 Lockdown on the Nutritional Status and Lipid Profile of Employees in a Teaching Hospital in Rome: A Retrospective Cohort Study

Observational Study

Published on 2022-04-092022-10-04
Journal: International Journal of Environmental Research an [Category] COVID19(2023년), SARS, 임상,

Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients

COVID-19 환자 집단에서 sCD163 혈장 수준을 하향 조절하는 토실리주맙의 역할

Article

Published on 2022-04-042022-09-12
Journal: Frontiers in Immunology [Category] 진단,

[키워드] anti-IL-6 receptor Biomarker both group CD163 Cell Clinical outcome clinical utility Cohort comparable control group COVID-19 COVID-19 patient COVID-19 patients defined died discharge down-regulated early stage ELISA enrolled evaluated expressed Follow-up group groups healthy donor Hospital admission Hospitalization IL-6 Inflammatory involved Laboratory parameters lethality rate Level Lineage macrophages mechanical ventilation monoclonal antibody monocyte monocytes/macrophages outcome plasma Pneumonia pro-inflammatory proteolytic cleavage receptor reduce reduction in reductions in Regulating Regulation required role SARS-CoV-2 sCD163 severity of COVID-19 statistically stratified TCZ the disease Tocilizumab Treatment
[DOI] 10.3389/fimmu.2022.871592 PMC 바로가기 [Article Type] Article

Identification of Natural SARS-CoV-2 Infection in Seroprevalence Studies Among Vaccinated Populations

백신 접종 집단 사이의 혈청유병성 연구에서 자연적인 SARS-CoV-2 감염의 확인

Article

Published on 2022-04-012022-09-11
Journal: Mayo Clinic proceedings [Category] COVID19(2023년), MERS, SARS, 진단, 치료법,

[키워드] 95% CI Accuracy age All participants an area antibody Antibody assays Antibody testing Area Blood can not capillary capillary blood Cohort composed conducted determine determined by elevated enrolled enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay female Health care Health care worker health care workers identification IgG IgG antibodies IgG antibody IgGs individual individuals Infection MOST natural natural infection nucleocapsid nucleocapsid protein participant Participants performed Population predicted Protein reactive reactivity reported SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 nucleocapsid separated Seroprevalence significantly specificity Spike protein Spike proteins statistically vaccinated individuals vaccination Vaccination Status was determined was tested were assessed
[DOI] 10.1016/j.mayocp.2022.02.002 PMC 바로가기 [Article Type] Article

Results of the treatment of patients with exudative AMD during the COVID-19 pandemic

Observational Study

Published on 2022-04-012022-10-05
Journal: Archivos de la Sociedad Española de Oftalmología [Category] COVID19(2023년), SARS, 임상, 치료법,

Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19

카시리비맙 및 임데비맙 단클론항체의 피하 또는 정맥내 투여와 COVID-19가 있는 성인의 임상 결과와의 연관성

Article

Published on 2022-04-012022-09-12
Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 진단,

[키워드] 95% CI adjusted administer Administered administration Admission adverse events age antibody association Casirivimab clinical clinically cohort study Control control group COVID-19 death decrease eligible eligible patient Emergency use authorization end point evaluate evaluated Evidence expand health system Hospitalization Imdevimab injection intensive care intravenous mAb mechanical ventilation Mild moderate Moderate COVID-19 no difference outcome Outpatient Patient patients patients treated Primary outcome prospective cohort study randomized clinical trial reduced risk risk ratio secondary single dose statistically Subcutaneous subcutaneous administration subcutaneously Symptom Symptoms Treatment women
[DOI] 10.1001/jamanetworkopen.2022.6920 PMC 바로가기 [Article Type] Article

Study of the effects of interferon β-1a on hospitalized patients with COVID-19: SBMU Taskforce on the COVIFERON study

입원한 COVID-19 환자에 대한 인터페론 β-1a의 효과 연구: COVIFERON 연구에 대한 SBMU 태스크포스

Article

Published on 2022-04-012022-09-11
Journal: Journal of medical virology [Category] Coronavirus, COVID19(2023년), SARS, 치료제,

[키워드] addition Antiviral conducted control group coronavirus disease Coronavirus disease 2019 COVID-19 died Effect Efficacy group hospital Hospital admission Hospital stay Hospitalized hospitalized COVID-19 patient hospitalized COVID-19 patients hospitalized patient hospitalized patients IFN-β1a immunomodulatory functions IMPROVE indicated innate immune system interferon Interferon β-1a interferons Iran median Mortality mortality rate no statistically significant difference outcome P-value Patient patients treated progression Randomized controlled trial regimen Retrospective study selected Severe case severe cases severe COVID-19 standard care standard treatment statistically statistically significant difference Tehran the interferon two group two groups
[DOI] 10.1002/jmv.27475 PMC 바로가기 [Article Type] Article

Analysis of long-term antibody response in COVID-19 patients by symptoms grade, gender, age, BMI, and medication

코로나19 환자의 증상 등급, 성별, 연령, 체질량지수(BMI), 약물 투여에 따른 장기 항체 반응 분석

Article

Published on 2022-04-012022-09-12
Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 진단,

[키워드] age anti-SARS-CoV-2 antibody antibody Antibody Response Antibody titer Antibody titers blood sample BMI body mass index chest pain chronic disease collected COVID-19 COVID-19 infection COVID-19 patient COVID-19 symptom Day Diseases duration of symptoms ELISA evaluated Favipiravir Fever Gender had no IgG IgG antibody IgG antibody titer immunoassay Immunoglobulin individual interval medication medications men Mild moderate not affect Older Older age parameters participant Participants Patient positive PSO SARS-CoV-2 antibody serum antibody severity of symptom Shortness of breath statistically Symptom the patient Therapies therapy Vitamin women
[DOI] 10.1002/jmv.27452 PMC 바로가기 [Article Type] Article

Aerosol generation during general anesthesia is comparable to coughing: An observational clinical study

Observational Study

Published on 2022-04-012022-10-05
Journal: Acta Anaesthesiologica Scandinavica [Category] 임상,